These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12654681)

  • 1. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
    Shalit I; Shadkchan Y; Samra Z; Osherov N
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
    Espinel-Ingroff A
    J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
    Pfaller MA; Diekema DJ; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1068-71. PubMed ID: 12604543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
    Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
    Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
    J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Diekema DJ; Messer SA; Hollis RJ; Jones RN; Pfaller MA
    J Clin Microbiol; 2003 Aug; 41(8):3623-6. PubMed ID: 12904365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
    Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
    Imhof A; Balajee SA; Marr KA
    J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
    Kachuei R; Khodavaisy S; Rezaie S; Sharifynia S
    J Mycol Med; 2016 Mar; 26(1):17-21. PubMed ID: 26852191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
    Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.